Evaluation of Longitudinal Lymphatic Function Changes upon Injury in the Mouse Tail with Photodynamic Therapy
- PMID: 36403192
- DOI: 10.1007/s13239-022-00645-z
Evaluation of Longitudinal Lymphatic Function Changes upon Injury in the Mouse Tail with Photodynamic Therapy
Abstract
Purpose: The lymphatic system is an essential but often understudied component of the circulatory system in comparison with its cardiovascular counterpart. Such disparity could often be explained by the difficulty in imaging lymphatics and the specialized microsurgical skills that are often required for lymphatic injury models. Recently, it has been shown that verteporfin, a photosensitive drug used for photodynamic therapy (PDT) to ablate the blood vessels, provides a similar effect on lymphatic vessels. Here, we seek to administer verteporfin and perform a modified form of PDT on collecting lymphatics in the mouse tail, a commonly used location for the study of lymphatic disorders, and examine lymphatic remodeling, contractility, and transport in response to the procedure.
Methods: Mice collecting lymphatics in the tail were injured by PDT through an intradermal injection of verteporfin in the distal tip of the tail followed by light activation on the proximal portion of the tail downstream of the injection site. Lymphatic function was evaluated using a near-infrared (NIR) imaging system weekly for up to 28 days after injury.
Results: PDT resulted in a loss in lymphatic function contractile frequency that persisted for up to 7 days after injury. Packet transport and packet amplitude, measurements reflective of the strength of contraction, were significantly reduced 14 days after injury. The lymphatics showed a delayed increase in lymphatic leakage at 7 days that persisted until the study endpoint on day 28.
Conclusion: This technique provides an easy-to-use method for injuring lymphatics to understand their remodeling response to injury by PDT as well as potentially for screening therapeutics that seek to normalize lymphatic permeability or contractile function after injury.
Keywords: Lymphatic injury; Lymphatic permeability; Lymphatics; NIR; Photodynamic therapy; Verteporfin.
© 2022. The Author(s) under exclusive licence to Biomedical Engineering Society.
Similar articles
-
Regression of mature lymphatic vessels in the cornea by photodynamic therapy.Br J Ophthalmol. 2014 Mar;98(3):391-5. doi: 10.1136/bjophthalmol-2013-303887. Epub 2014 Jan 10. Br J Ophthalmol. 2014. PMID: 24414403
-
Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis.Angiogenesis. 2014 Apr;17(2):347-57. doi: 10.1007/s10456-013-9365-6. Epub 2013 Jul 28. Angiogenesis. 2014. PMID: 23892627 Free PMC article.
-
Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5862-5869. doi: 10.1167/iovs.17-22904. Invest Ophthalmol Vis Sci. 2017. PMID: 29145577
-
Mechanical forces and lymphatic transport.Microvasc Res. 2014 Nov;96:46-54. doi: 10.1016/j.mvr.2014.07.013. Epub 2014 Aug 5. Microvasc Res. 2014. PMID: 25107458 Free PMC article. Review.
-
Verteporfin PDT for non-standard indications--a review of current literature.Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):613-26. doi: 10.1007/s00417-010-1307-z. Epub 2010 Feb 17. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20162298 Review.
Cited by
-
Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities.Front Cardiovasc Med. 2024 Jun 10;11:1412857. doi: 10.3389/fcvm.2024.1412857. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38915742 Free PMC article. Review.
References
-
- Abrahamse, H., and M. R. Hamblin. New photosensitizers for photodynamic therapy. Biochem. J. 473:347–364, 2016. https://doi.org/10.1042/BJ20150942 . - DOI - PubMed
-
- Baluk, P., J. Fuxe, H. Hashizume, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204:2349–2362, 2007. https://doi.org/10.1084/jem.20062596 . - DOI - PubMed - PMC
-
- Bausch & Lomb Incorporated. VISUDYNE (Package Insert). Bausch & Lomb Incorporated, 2000. https://www.bausch.com/globalassets/pdf/packageinserts/pharma/visudyne-p... .
-
- Bernard, F. C., J. Kaiser, S. K. Raval, et al. Multichromatic near-infrared imaging to assess interstitial lymphatic and venous uptake in vivo. J. Biomed. Opt. 2021. https://doi.org/10.1117/1.jbo.26.12.126001 . - DOI - PubMed - PMC
-
- Bouta, E. M., C. Blatter, T. A. Ruggieri, et al. Lymphatic function measurements influenced by contrast agent volume and body position. JCI Insights. 2018. https://doi.org/10.1172/jci.insight.96591 . - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous